© 2006 The Japanese Biochemical Society.
Regular Paper |
Proinsulin C-Peptide Stimulates a PKC/I
B/NF-
B Signaling Pathway to Activate COX-2 Gene Transcription in Swiss 3T3 Fibroblasts
1 Department of Pharmaceutical Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-ku, Sendai 980-8578; 2 Molecular Medicine Laboratories, Institute for Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585; and 3 Yokohama College of Pharmacy, 601 Matano-cho, Tozuka-ku, Yokohama 245-0066
* To whom correspondence should be addressed. Tel: +81-22-795-6852, Fax: +81-22-795-6850, E-mail: yamakuni{at}mail.pharm.tohoku.ac.jp
Proinsulin C-peptide causes multiple molecular and physiological effects, and improves renal and neuronal dysfunction in patients with diabetes. However, whether C-peptide controls the inhibitor
B (I
B)/NF-
Bdependent transcription of genes, including inflammatory genes is unknown. Here we showed that 1 nM C-peptide increased the expression of cyclooxygenase-2 (COX-2) mRNA and its protein in Swiss 3T3 fibroblasts. Consistently, C-peptide enhanced COX-2 gene promoter-activity, which was inhibited by GF109203X and Go6976, specific PKC inhibitors, and BAY11-7082, a specific nuclear factor-
B (NF-
B) inhibitor, accompanied by increased phosphorylation and degradation of I
B. These results suggest that C-peptide stimulates the transcription of inflammatory genes via activation of a PKC/I
B/NF-
B signaling pathway.